The interesting finding reported in IJC by Po-Min Chen et al. [1] in regard to nardilysin as a potential early marker of acute coronary syndrome, is even more intriguing now keeping in mind the very recent report by Ito et al. [2]. The latter manuscript claims that in vitro platelet production from induced pluripotent stem cell (iPS) precursors is largely increased by applying turbulent forces in the in vitro system designed by the authors, scaling platelet yield and quality at a clinical meaningful level and paving the way for a realistic alternative to transfusion for platelet supply

Nardilysin: A potential biomarker for the early diagnosis of acute coronary syndrome

Vaccarezza Mauro
2019-01-01

Abstract

The interesting finding reported in IJC by Po-Min Chen et al. [1] in regard to nardilysin as a potential early marker of acute coronary syndrome, is even more intriguing now keeping in mind the very recent report by Ito et al. [2]. The latter manuscript claims that in vitro platelet production from induced pluripotent stem cell (iPS) precursors is largely increased by applying turbulent forces in the in vitro system designed by the authors, scaling platelet yield and quality at a clinical meaningful level and paving the way for a realistic alternative to transfusion for platelet supply
File in questo prodotto:
File Dimensione Formato  
IJC 2019.pdf

non disponibili

Descrizione: Stephenson Vaccarezza IJC 2019
Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 187.05 kB
Formato Adobe PDF
187.05 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11580/72452
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
social impact